PSMA

作品数:291被引量:580H指数:11
导出分析报告
相关领域:医药卫生理学更多>>
相关作者:杨志朱华崔孟超郭正辉黄海更多>>
相关机构:空军军医大学(第四军医大学)复旦大学附属肿瘤医院中山大学空军军医大学更多>>
相关期刊:更多>>
相关基金:国家自然科学基金广东省自然科学基金北京市自然科学基金国家重点基础研究发展计划更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Asian Journal of Andrologyx
条 记 录,以下是1-7
视图:
排序:
PSMA PET/CT in the low-to intermediate-risk prostate cancer:when and why?被引量:1
《Asian Journal of Andrology》2024年第6期584-586,共3页Luca Sofia Matteo Bauckneht 
Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) represents a significant advancement in the imaging of prostate cancer (PCa), yet its application in low- and intermedi...
关键词:ROUTINE INTERMEDIATE treatment 
^(68)Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy被引量:3
《Asian Journal of Andrology》2022年第1期97-101,共5页Teng-Cheng Li Yu Wang Chu-Tian Xiao Ming-Zhao Li Xiao-Peng Liu Wen-Tao Huang Liao-Yuan Li Ke Li Jin-Ming Di Xing-Qiao Wen Xin Gao 
This work was supported by the National Natural Science Foundation of China(General Program,No.81772722);Guangdong Province Science and Technology Planning Project(No.2017B020227008).
To efficiently remove all recurrent lymph nodes(rLNs)and minimize complications,we developed a combination approach that consisted of ^(68)Gallium prostate-specific membrane antigen(PSMA)ligand positron emission tomog...
关键词:indocyanine green prostate cancer recurrent lymph node salvage lymph node dissection 
The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
《Asian Journal of Andrology》2021年第1期1-2,共2页Jeanny B Aragon-Ching 
The proPSMA trial is a Phase III multicentric trial that examined the role of gallium-68-prostate-specific membrane an tigen(PSMA)-p o sitro n em issio n tomography/computed tomography(PET/CT)scan versus conventional ...
关键词:PSMA high finding 
PSMA-targeted imaging of prostate cancer: evolution of a success story
《Asian Journal of Andrology》2017年第3期388-388,共1页Tobias Maurer Matthias Eiber 
Management of prostate cancer patients with biochemical relapse has long hampered due to insufficient capability to detect and localize recurrent disease with available imaging modalities such as CT, MRI, or bone scin...
Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse被引量:4
《Asian Journal of Andrology》2017年第3期267-271,共5页Heng-Chuan Su Yao Zhu Guo-Wen Ling Si-Long Hu Xiao-Ping Xu Bo Dai Ding-Wei Ye 
Using conventional imaging modalities, it is difficult to detect recurrent lesions in prostate cancer patients who have undergone biochemical relapse, especially in patients with low prostate-specific antigen (PSA) ...
关键词:99mTc CT prostate cancer PSMA SPECT 
New developments in the treatment of castration resistant prostate cancer
《Asian Journal of Andrology》2014年第4期555-560,共6页Roxanne Wadia Daniel P Petrylak 
In the past 5 years, the treatment and understanding of metastatic castrate resistant prostate cancer (CRPC) have improved dramatically. Our understanding of the mechanisms of castration resistance has allowed for t...
关键词:castration resistant prostate cancer ABIRATERONE enzalutamide chemotherapy DOCETAXEL CABAZITAXEL PSMA antibody 
Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter被引量:7
《Asian Journal of Andrology》2014年第1期120-123,共4页Xiao-Feng Gao Tie Zhou Guang-Hua Chen Chuan-Liang Xu Ye-Lei Ding Ying-Hao Sun 
Radioiodine therapy, the most effective form of systemic radiotherapy available, is currently useful only for thyroid cancer because of the thyroid-specific expression of the human sodium iodide symporter (hNIS). He...
关键词:genetic therapy prostate-specific membrane antigen (PSMA) prostatic neoplasms sodium-iodide symporter 
检索报告 对象比较 聚类工具 使用帮助 返回顶部